SB1214: RARE Act Retaining Access and Restoring Exclusivity Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
Plain-language summary
The RARE Act limits how long pharmaceutical companies can have exclusive rights to sell drugs for rare diseases. Rare diseases affect very few people, and exclusive approval means only one company can sell a particular drug for that condition. This bill sets rules on how long that exclusivity lasts and when other companies can enter the market. Sponsors include Senators Tammy Baldwin and Mike Braun. The bill was recently introduced in Congress and has not yet been assigned to a .
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB1214: RARE Act Retaining Access and Restoring Exclusivity Act